Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries-Reference-Cited by-同舟云学术

Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries

Published:2018-11-21 Issue: Volume:7 Page:1-8
ISSN:1740-4398
Container-title:Drugs in Context
language:
Short-container-title:DIC

Author:

Opris-Belinski Daniela,Erdes Shandor F,Grazio Simeon,Šenolt Ladislav,Hojnik Maja,Nagy Orsolya,Marina Diana,Szántó Sándor

Publisher

BioExcel

Subject

Pharmacology,Molecular Medicine,General Medicine

Link

https://www.drugsincontext.com/wp-content/uploads/2018/11/dic.212556.pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Adalimumab Therapy for Ankylosing Spondylitis;Current Rheumatology Reviews;2024-12

2. Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry;Rheumatology and Therapy;2022-11-04

3. The Association Between TNF Inhibitor Therapy Availability and Hospital Admission Rates for Patients with Ankylosing Spondylitis. A Longitudinal Population-Based Study;Rheumatology and Therapy;2021-11-11

4. Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real-world study;Clinical Rheumatology;2021-07-28

5. Functional hindrance, comorbid depression and early development of restrictive lung disease are linked to ankylosing spondylitis patients’ withdrawal from the workforce;Revista Medico-Chirurgicala;2021-06-30